Thromboembolic complications in critically ill COVID-19 patients are associated with impaired fibrinolysis

BACKGROUND: There is emerging evidence for enhanced blood coagulation in coronavirus 2019 (COVID-19) patients, with thromboembolic complications contributing to morbidity and mortality. The mechanisms underlying this prothrombotic state remain enigmatic. Further data to guide anticoagulation strateg...

Descripción completa

Detalles Bibliográficos
Autores principales: Kruse, Jan Matthias, Magomedov, Abakar, Kurreck, Annika, Münch, Frédéric H., Koerner, Roland, Kamhieh-Milz, Julian, Kahl, Andreas, Gotthardt, Inka, Piper, Sophie K., Eckardt, Kai-Uwe, Dörner, Thomas, Zickler, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7719734/
https://www.ncbi.nlm.nih.gov/pubmed/33287877
http://dx.doi.org/10.1186/s13054-020-03401-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7719734/
https://www.ncbi.nlm.nih.gov/pubmed/33287877
http://dx.doi.org/10.1186/s13054-020-03401-8

Ejemplares similares